 |
Esmaspäev, 11. juuni 2018
|
| 08:40-09:00 |
Registreerimine |
 |
| 09:00 | KONVERENTSI AVAMINE |
| | Dr. Kristjan Vassil, Vice-Rector for Research, University of Tartu, Estonia |
| | Dr. Tõnu Esko, Vice Director, Institute of Genomics, University of Tartu, Estonia |
|
| 09:10-10:30 |
AVASESSIOON
Population scale genomics (Chair: Tõnu Esko) |
| | Radja M. Badji, Qatar Foundation, Doha, Qatar
"Qatar Genome Project" |
| | Paul Jones, Director – Population Genomics, Illumina Inc.,
"An Industry Interface into Population Genetics at Scale" |
|
| 10:30-10:45 |
Kohvi / tee |
|
| 10:45-12:45 |
I SESSIOON
Microbiome in health and disease (Chair: Elin Org) |
| | Max Nieuwdorp, University of Gothenburg, AMC-VUMC Diabetes Center, Sweden
“Role of gutmicrobiota in development of human disease, causality of merely innocent association?” |
| | Egija Zaura, Vrije Universiteit Amsterdam, The Netherlands
"Oral microbiome: the friend or the foe?” |
| | Jacques S Beckmann, University of Lausanne, Switzerland
“Beyond the Human Genome: The Microbiome, Impact on Health and Disease” |
|
| 12:45-13:50 |
Lõuna |
|
| 13:50-15:50 |
II SESSIOON
Genomics in clinic (Chair: Maris Laan) |
| | Lars Forsberg, Uppsala Universitet, Sweden
“What happens in leukocytes losing the Y chromosome? Consequences single cells and risk for disease in aging men” |
| | Joris Veltman, Institute of Genetic Medicine, Newcastle University, UK
“Genome diagnostics in human disease, from intellectual disability to male infertility” |
| | Gregg Wagner, Population Health Division, Metabolon Inc, US
“Metabolomics enhances precision medicine and the understanding of genomic variation” |
|
| 15:50-16:10 |
Kohvi / tee |
|
| 16:10-17:25 |
III SESSIOON
Genomics of recreational traits (Chair: Andres Metspalu ) |
| | Irma Järvelä, Department of Medical Genetics, University of Helsinki, Finland
“Genomics approaches to study musical aptitude, music perception and practice” |
| | Taavi Tillmann, University College London, UK
“Disease prevention from a public health perspective, and genomic opportunities” |
|
| 20:00 | Õhtusöök (Dorpati Konverentsikeskuses) |
|
|
Teisipäev, 12. juuni 2018
|
| 09:30-11:30 |
IV SESSIOON
Genetic architecture and evolution (Chair: Mait Metspalu) |
| | Joseph Lachance, School of Biological Sciences, Georgia Institute of Technology, USA
“Evolutionary history and hereditary disease risks in ancient and modern humans" |
| | Anders Eriksson, King's College of London, UK
"The complex evolutionary history of genes regulating inflammatory response in humans" |
| | Doug Speed, Aarhus University and University College London, UK
“Better Estimation of SNP heritability from summary statistics provides a new understanding of the genetic architecture of complex traits" |
|
| 11:30-11:50 |
Kohvi / tee |
|
| 11:50-13:50 |
V SESSIOON
Novel targets for drug discovery (Chair: Lili Milani) |
| | Lasse Folkersen, Sankt Hans Hospital, Institute for psychiatric biology, Denmark
“Large scale SNP to protein level association mapping and its applications for functional genetics” |
| | Adam Butterworth, University of Cambridge, UK
“Integrating genomic and other ‘omic data to inform disease aetiology and therapeutic target prioritisation” |
| | Volker Lauschke, Karolinska Institutet, Sweden
"Novel hepatic spheroid systems for drug discovery and development” |
|
| 13:50-14:40 |
Lõuna |
|
| 14:40-16:00 |
VI SESSIOON
Innovation in healthcare (Chair: Reedik Mägi) |
| | Paul Lacaze, Public Health Genomics Program, Monash University, Australia
“Genomic sequencing & deep phenotyping of large clinical trial cohorts in Australia” |
| | Emmi Tikkanen, Nightingale Health Ltd,
“Comprehensive biomarker profiling: from biobanks to general healthcare – Nightingale Health perspective” |
|
| 16:00 | Konverentsi lõpetamine |
|
